Aarti Pharmalabs Limited (AARTIPHARM.BO)
INR 577.0
(2.11%)
INR 577.0
(2.11%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 18.15 Billion INR | -4.76% |
| 2022 | 19.45 Billion INR | 62.98% |
| 2021 | 11.93 Billion INR | 0.0% |
| 2020 | - INR | 0.0% |
| 2019 | - INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 4.58 Billion INR | -17.55% |
| 2024 Q1 | 5.55 Billion INR | 9.83% |
| 2023 Q3 | 4.48 Billion INR | 2.02% |
| 2023 FY | 18.52 Billion INR | -4.76% |
| 2023 Q4 | 5.05 Billion INR | 12.72% |
| 2023 Q2 | 4.39 Billion INR | -4.05% |
| 2023 Q1 | 4.58 Billion INR | -7.08% |
| 2022 Q3 | 4.63 Billion INR | -12.77% |
| 2022 FY | 19.45 Billion INR | 62.98% |
| 2022 Q2 | 5.31 Billion INR | 7.68% |
| 2022 Q1 | 4.93 Billion INR | -17.78% |
| 2022 Q4 | 4.93 Billion INR | 6.46% |
| 2021 Q2 | - INR | 0.0% |
| 2021 Q1 | - INR | 0.0% |
| 2021 Q4 | 5.99 Billion INR | 0.0% |
| 2021 Q3 | 5.99 Billion INR | 0.0% |
| 2021 FY | 11.93 Billion INR | 0.0% |
| 2020 FY | - INR | 0.0% |
| 2019 FY | - INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Ajanta Pharma Limited | 42.08 Billion INR | 56.863% |
| Amrutanjan Health Care Limited | 4.21 Billion INR | -331.0% |
| Sigachi Industries Limited | 3.98 Billion INR | -355.064% |
| Bal Pharma Limited | 3.39 Billion INR | -435.201% |
| Ind-Swift Laboratories Limited | 12.8 Billion INR | -41.737% |
| Medico Remedies Limited | 1.44 Billion INR | -1152.758% |
| Lasa Supergenerics Limited | 1.04 Billion INR | -1640.073% |
| Venus Remedies Limited | 5.91 Billion INR | -206.959% |
| Sun Pharma Advanced Research Company Limited | 755.45 Million INR | -2303.201% |
| Alpa Laboratories Limited | 1.08 Billion INR | -1569.599% |
| Nectar Lifesciences Limited | 16.84 Billion INR | -7.804% |
| Shilpa Medicare Limited | 11.51 Billion INR | -57.65% |
| Aarti Drugs Limited | 25.28 Billion INR | 28.201% |
| Lupin Limited | 200.1 Billion INR | 90.927% |
| Aurobindo Pharma Limited | 287.04 Billion INR | 93.675% |
| Zydus Lifesciences Limited | 190.21 Billion INR | 90.456% |
| Windlas Biotech Limited | 6.3 Billion INR | -187.739% |
| Suven Life Sciences Limited | 116.92 Million INR | -15426.561% |
| Eris Lifesciences Limited | 20.09 Billion INR | 9.638% |
| Valiant Laboratories Limited | 1.82 Billion INR | -897.217% |
| J. B. Chemicals & Pharmaceuticals Limited | 34.84 Billion INR | 47.893% |
| Solara Active Pharma Sciences Limited | 12.38 Billion INR | -46.602% |
| Ipca Laboratories Limited | 76.22 Billion INR | 76.182% |
| Bliss GVS Pharma Limited | 7.7 Billion INR | -135.705% |
| Achyut Healthcare Limited | 61.36 Million INR | -29483.425% |
| Sun Pharmaceutical Industries Limited | 484.96 Billion INR | 96.256% |
| Bajaj HealthCare Limited | 4.73 Billion INR | -283.489% |
| RPG Life Sciences Limited | 5.82 Billion INR | -211.916% |
| Mankind Pharma Limited | 103.34 Billion INR | 82.433% |
| Laurus Labs Limited | 50.01 Billion INR | 63.703% |
| Piramal Pharma Limited | 81.71 Billion INR | 77.782% |
| Syncom Formulations (India) Limited | 2.59 Billion INR | -600.308% |
| Torrent Pharmaceuticals Limited | 106.05 Billion INR | 82.881% |
| Alembic Pharmaceuticals Limited | 61.12 Billion INR | 70.297% |
| Glenmark Pharmaceuticals Limited | 118.13 Billion INR | 84.631% |
| Unichem Laboratories Limited | 16.57 Billion INR | -9.538% |
| Sequent Scientific Limited | 13.69 Billion INR | -32.545% |
| Novartis India Limited | 3.35 Billion INR | -441.829% |
| Wanbury Limited | 5.75 Billion INR | -215.384% |
| Suven Pharmaceuticals Limited | 10.51 Billion INR | -72.683% |
| Wockhardt Limited | 27.89 Billion INR | 34.905% |
| Themis Medicare Limited | 3.81 Billion INR | -375.561% |
| Jagsonpal Pharmaceuticals Limited | 2.08 Billion INR | -769.903% |
| Jubilant Pharmova Limited | 67.02 Billion INR | 72.915% |
| Glenmark Life Sciences Limited | 22.83 Billion INR | 20.485% |
| Dr. Reddy's Laboratories Limited | 279.16 Billion INR | 93.497% |
| Divi's Laboratories Limited | 78.45 Billion INR | 76.858% |
| NATCO Pharma Limited | 40.02 Billion INR | 54.635% |
| Gufic Biosciences Limited | 8.06 Billion INR | -125.063% |
| IOL Chemicals and Pharmaceuticals Limited | 21.18 Billion INR | 14.321% |
| Ind-Swift Limited | 5.02 Billion INR | -261.318% |
| Procter & Gamble Health Limited | 11.51 Billion INR | -57.697% |
| FDC Limited | 19.42 Billion INR | 6.559% |
| Krebs Biochemicals & Industries Limited | 504.21 Million INR | -3500.657% |
| Granules India Limited | 45.06 Billion INR | 59.712% |
| Medicamen Biotech Limited | 1.79 Billion INR | -912.517% |
| Alkem Laboratories Limited | 126.67 Billion INR | 85.668% |
| AstraZeneca Pharma India Limited | 12.95 Billion INR | -40.136% |
| Biofil Chemicals and Pharmaceuticals Limited | 400.35 Million INR | -4434.761% |
| Brooks Laboratories Limited | 794.86 Million INR | -2184.054% |
| Megasoft Limited | 373.95 Million INR | -4754.902% |
| ZIM Laboratories Limited | 3.67 Billion INR | -394.117% |
| Strides Pharma Science Limited | 40.51 Billion INR | 55.185% |
| Neuland Laboratories Limited | 15.58 Billion INR | -16.485% |
| Morepen Laboratories Limited | 17.01 Billion INR | -6.675% |
| Hikal Limited | 17.84 Billion INR | -1.732% |
| Indoco Remedies Limited | 17.89 Billion INR | -1.456% |
| Kilitch Drugs (India) Limited | 1.54 Billion INR | -1076.055% |
| Mangalam Drugs & Organics Limited | 3.68 Billion INR | -392.548% |
| Hester Biosciences Limited | 3.04 Billion INR | -496.135% |